Therefore, this study evaluated the clinicopathological characteristics of patients with the ER-/PR + phenotype and the pCR rate after NAC compared to BC patients with other phenotypes (ER + /PR + , ER + /PR-, ER-/PR-). This evidence concerns the gene PGR and breast cancer.